RANDOMIZED PHASE-III TRIAL OF ACTIVE SPECIFIC IMMUNOTHERAPY (ASI) VERSUS CONTROL IN PATIENTS WITH DUKES B2, B3 OR C COLON-CANCER

Authors
VERMORKEN JB CLAESSEN A GALL H VANHOLTEN A VANTINTEREN H MEIJER S STEFFELAAR H BRAKENHOFF J VANBOCHOVE A SCHEPER R MEIJER C HANNA M PINEDO H
Citation
Jb. Vermorken et al., RANDOMIZED PHASE-III TRIAL OF ACTIVE SPECIFIC IMMUNOTHERAPY (ASI) VERSUS CONTROL IN PATIENTS WITH DUKES B2, B3 OR C COLON-CANCER, European journal of cancer, 33, 1997, pp. 722-722
Citations number
NO
Categorie Soggetti
Oncology
Journal title
European journal of cancer → ACNP
ISSN journal
09598049
Volume
33
Year of publication
1997
Supplement
8
Pages
722 - 722
Database
ISI
SICI code
0959-8049(1997)33:<722:RPTOAS>2.0.ZU;2-U